Fosun Pharma's shareholder unwinds part of pledge

Shanghai Fosun Pharmaceutical Group (Fosun Pharma) announced that its controlling shareholder, Fosun High Technology, has released 59 million shares of the company from pledge. Following the release, Fosun High Technology’s remaining pledged shares amount to 648.3 million, representing 24.27% of Fosun Pharma's total shares. In related news, Fosun Pharma announced a RMB 30 million capital injection into its subsidiary, Shanghai Zhuo'er, to boost development and brand expansion. After the capital injection, Fosun Healthcare will hold 67.1872% stake in Shanghai Zhuo'er. Fosun Pharma stated this transactions will not impact on the company's financials and operations.